Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX208 in advanced anaplastic thyroid cancer
NCT05102292Phase 2Unknown
- Sponsor
- Henlius
- Start
- Dec 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HLX208 in anaplastic thyroid cancer (ATC), sponsored by Henlius. Status: unknown.
02
Drugs
HLX208
03
Conditions
anaplastic thyroid cancer (ATC)
Beyond the preview
Go deeper on NCT05102292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05102292.